The suppression of RASSF6 is demonstrated at the mRNA level in clear cell renal carcinoma, pancreatic cancer, gastric cancer and metastatic nasopharyngeal cancer cell lines [31,48,49,50]. Here, RASSF6 is linked to pancreatic neoplasm.